title: Bronchial reactivity, lung function, and serum immunoglobulin E in smoking-discordant monozygotic twins.
abstract: Smokers with chronic bronchitis and/or chronic obstructive pulmonary disease (COPD) have been reported to have an increased bronchial reactivity (BR). It has been discussed whether increased BR is a risk factor for the development of COPD in smokers. We studied 10 monozygotic twin pairs who were discordant for tobacco smoking by means of histamine provocation tests, lung function tests, and serum samples for total IgE. The smokers had a mild obstructive ventilatory impairment, with FEV1 significantly lower than that of the partner both when it was determined from the flow-volume loops (3.2 +/- 1.0 L for smokers and 3.4 +/- 0.8 L for nonsmokers) and by the Vitalograph spirometer (3.5 +/- 1.0 L for smokers and 3.8 +/- 0.8 L for nonsmokers). Forced midexpiratory flow (FEF25-75%) and forced expiratory flow at 75 to 85% of vital capacity (FEF75-85%) were both significantly lower in the smokers (p < 0.05). The alveolar plateau phase N2-delta test and lung clearing index in the multibreath nitrogen washout test were both significantly affected in the smokers (p < 0.05 and p < 0.01, respectively). We found no significant difference in histamine reactivity between smokers and nonsmokers and no correlation between differences in reactivity and differences in lung function within pairs. Total serum IgE was significantly higher in the smokers than in their nonsmoking siblings. These data suggest that obstructive ventilatory impairment and raised serum IgE are earlier and more constant manifestations of tobacco smoking than increased bronchial reactivity. Thus, bronchial hyperreactivity does not seem to be a major risk factor for the development of early airways obstruction in smokers.
authors.affiliation: Department of Respiratory Medicine and Allergology, Södersjukhuset, Stockholm, Sweden.
authors.forename: C H
authors.initials: CH
authors.lastname: Ericsson
authors.forename: M
authors.initials: M
authors.lastname: Svartengren
authors.forename: B
authors.initials: B
authors.lastname: Mossberg
authors.forename: P
authors.initials: P
authors.lastname: Camner
mesh_terms: D000328:Adult; D016535:Bronchial Hyperreactivity / Q000276:immunology / Q000503:physiopathology*; D001985:Bronchial Provocation Tests; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood*; D008168:Lung / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D012882:Skin Tests; D012907:Smoking / Q000276:immunology / Q000503:physiopathology*; D014430:Twins, Monozygotic; D014797:Vital Capacity
chemical_list: D007073:Immunoglobulin E